2024-04-012025-03-312025-03-31false07444210ABC Surgical Limited2025-11-04falseiso4217:GBPxbrli:pure074442102024-03-31074442102025-03-31074442102024-04-012025-03-31074442102023-03-31074442102024-03-31074442102023-04-012024-03-3107444210bus:SmallEntities2024-04-012025-03-3107444210bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3107444210bus:FullAccounts2024-04-012025-03-3107444210bus:PrivateLimitedCompanyLtd2024-04-012025-03-3107444210core:WithinOneYear2025-03-3107444210core:AfterOneYear2025-03-3107444210core:WithinOneYear2024-03-3107444210core:AfterOneYear2024-03-3107444210core:ShareCapital2025-03-3107444210core:SharePremium2025-03-3107444210core:RevaluationReserve2025-03-3107444210core:OtherReservesSubtotal2025-03-3107444210core:RetainedEarningsAccumulatedLosses2025-03-3107444210core:ShareCapital2024-03-3107444210core:SharePremium2024-03-3107444210core:RevaluationReserve2024-03-3107444210core:OtherReservesSubtotal2024-03-3107444210core:RetainedEarningsAccumulatedLosses2024-03-3107444210core:LandBuildings2025-03-3107444210core:PlantMachinery2025-03-3107444210core:Vehicles2025-03-3107444210core:FurnitureFittings2025-03-3107444210core:OfficeEquipment2025-03-3107444210core:NetGoodwill2025-03-3107444210core:IntangibleAssetsOtherThanGoodwill2025-03-3107444210core:ListedExchangeTraded2025-03-3107444210core:UnlistedNon-exchangeTraded2025-03-3107444210core:LandBuildings2024-03-3107444210core:PlantMachinery2024-03-3107444210core:Vehicles2024-03-3107444210core:FurnitureFittings2024-03-3107444210core:OfficeEquipment2024-03-3107444210core:NetGoodwill2024-03-3107444210core:IntangibleAssetsOtherThanGoodwill2024-03-3107444210core:ListedExchangeTraded2024-03-3107444210core:UnlistedNon-exchangeTraded2024-03-3107444210core:LandBuildings2024-04-012025-03-3107444210core:PlantMachinery2024-04-012025-03-3107444210core:Vehicles2024-04-012025-03-3107444210core:FurnitureFittings2024-04-012025-03-3107444210core:OfficeEquipment2024-04-012025-03-3107444210core:NetGoodwill2024-04-012025-03-3107444210core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3107444210core:ListedExchangeTraded2024-04-012025-03-3107444210core:UnlistedNon-exchangeTraded2024-04-012025-03-3107444210core:MoreThanFiveYears2024-04-012025-03-3107444210core:Non-currentFinancialInstruments2025-03-3107444210core:Non-currentFinancialInstruments2024-03-3107444210dpl:CostSales2024-04-012025-03-3107444210dpl:DistributionCosts2024-04-012025-03-3107444210core:LandBuildings2024-04-012025-03-3107444210core:PlantMachinery2024-04-012025-03-3107444210core:Vehicles2024-04-012025-03-3107444210core:FurnitureFittings2024-04-012025-03-3107444210core:OfficeEquipment2024-04-012025-03-3107444210dpl:AdministrativeExpenses2024-04-012025-03-3107444210core:NetGoodwill2024-04-012025-03-3107444210core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3107444210dpl:GroupUndertakings2024-04-012025-03-3107444210dpl:ParticipatingInterests2024-04-012025-03-3107444210dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3107444210core:ListedExchangeTraded2024-04-012025-03-3107444210dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3107444210core:UnlistedNon-exchangeTraded2024-04-012025-03-3107444210dpl:CostSales2023-04-012024-03-3107444210dpl:DistributionCosts2023-04-012024-03-3107444210core:LandBuildings2023-04-012024-03-3107444210core:PlantMachinery2023-04-012024-03-3107444210core:Vehicles2023-04-012024-03-3107444210core:FurnitureFittings2023-04-012024-03-3107444210core:OfficeEquipment2023-04-012024-03-3107444210dpl:AdministrativeExpenses2023-04-012024-03-3107444210core:NetGoodwill2023-04-012024-03-3107444210core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3107444210dpl:GroupUndertakings2023-04-012024-03-3107444210dpl:ParticipatingInterests2023-04-012024-03-3107444210dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3107444210core:ListedExchangeTraded2023-04-012024-03-3107444210dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3107444210core:UnlistedNon-exchangeTraded2023-04-012024-03-3107444210core:NetGoodwill2025-03-3107444210core:IntangibleAssetsOtherThanGoodwill2025-03-3107444210core:LandBuildings2025-03-3107444210core:PlantMachinery2025-03-3107444210core:Vehicles2025-03-3107444210core:FurnitureFittings2025-03-3107444210core:OfficeEquipment2025-03-3107444210core:AfterOneYear2025-03-3107444210core:WithinOneYear2025-03-3107444210core:ListedExchangeTraded2025-03-3107444210core:UnlistedNon-exchangeTraded2025-03-3107444210core:ShareCapital2025-03-3107444210core:SharePremium2025-03-3107444210core:RevaluationReserve2025-03-3107444210core:OtherReservesSubtotal2025-03-3107444210core:RetainedEarningsAccumulatedLosses2025-03-3107444210core:NetGoodwill2024-03-3107444210core:IntangibleAssetsOtherThanGoodwill2024-03-3107444210core:LandBuildings2024-03-3107444210core:PlantMachinery2024-03-3107444210core:Vehicles2024-03-3107444210core:FurnitureFittings2024-03-3107444210core:OfficeEquipment2024-03-3107444210core:AfterOneYear2024-03-3107444210core:WithinOneYear2024-03-3107444210core:ListedExchangeTraded2024-03-3107444210core:UnlistedNon-exchangeTraded2024-03-3107444210core:ShareCapital2024-03-3107444210core:SharePremium2024-03-3107444210core:RevaluationReserve2024-03-3107444210core:OtherReservesSubtotal2024-03-3107444210core:RetainedEarningsAccumulatedLosses2024-03-3107444210core:NetGoodwill2023-03-3107444210core:IntangibleAssetsOtherThanGoodwill2023-03-3107444210core:LandBuildings2023-03-3107444210core:PlantMachinery2023-03-3107444210core:Vehicles2023-03-3107444210core:FurnitureFittings2023-03-3107444210core:OfficeEquipment2023-03-3107444210core:AfterOneYear2023-03-3107444210core:WithinOneYear2023-03-3107444210core:ListedExchangeTraded2023-03-3107444210core:UnlistedNon-exchangeTraded2023-03-3107444210core:ShareCapital2023-03-3107444210core:SharePremium2023-03-3107444210core:RevaluationReserve2023-03-3107444210core:OtherReservesSubtotal2023-03-3107444210core:RetainedEarningsAccumulatedLosses2023-03-3107444210core:AfterOneYear2024-04-012025-03-3107444210core:WithinOneYear2024-04-012025-03-3107444210core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3107444210core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3107444210core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3107444210core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3107444210core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3107444210core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3107444210core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3107444210core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3107444210core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3107444210core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3107444210core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3107444210core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3107444210core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3107444210core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3107444210core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3107444210core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3107444210core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3107444210core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3107444210core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3107444210core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3107444210core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3107444210core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3107444210core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3107444210core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3107444210core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3107444210core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3107444210core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3107444210bus:Director12024-04-012025-03-31

ABC Surgical Limited

Registered Number
07444210
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

ABC Surgical Limited
Company Information
for the year from 1 April 2024 to 31 March 2025

Director

Dr Sarah O'Dwyer

Registered Address

The Beeches Consulting Centre
Mill Lane
Cheadle
SK8 2PY

Registered Number

07444210 (England and Wales)
ABC Surgical Limited
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets31,31816,876
1,31816,876
Current assets
Debtors420,80310,750
Current asset investments51,080,610988,647
Cash at bank and on hand829,308264,389
1,930,7211,263,786
Creditors amounts falling due within one year6(198,053)(66,002)
Net current assets (liabilities)1,732,6681,197,784
Total assets less current liabilities1,733,9861,214,660
Provisions for liabilities7(330)(2,389)
Net assets1,733,6561,212,271
Capital and reserves
Called up share capital100100
Profit and loss account1,733,5561,212,171
Shareholders' funds1,733,6561,212,271
The financial statements were approved and authorised for issue by the Director on 4 November 2025, and are signed on its behalf by:
Dr Sarah O'Dwyer
Director
Registered Company No. 07444210
ABC Surgical Limited
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Vehicles25
Office Equipment25
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
2.Average number of employees

20252024
Average number of employees during the year11
3.Tangible fixed assets

Plant & machinery

Vehicles

Office Equipment

Total

££££
Cost or valuation
At 01 April 244,30236,3884,70145,391
Additions--583583
Disposals(4,302)(36,388)-(40,690)
At 31 March 25--5,2845,284
Depreciation and impairment
At 01 April 24-24,8753,64028,515
Charge for year-2,3993262,725
On disposals-(27,274)-(27,274)
At 31 March 25--3,9663,966
Net book value
At 31 March 25--1,3181,318
At 31 March 244,30211,5131,06116,876
4.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables20,75110,750
Other debtors52-
Total20,80310,750
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
5.Current asset investments
6.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables38724
Taxation and social security186,30757,863
Other creditors8,7675,715
Accrued liabilities and deferred income2,5922,400
Total198,05366,002
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
7.Provisions for liabilities

2025

2024

££
Net deferred tax liability (asset)3302,389
Total3302,389